Amir Boshra
Dubai, DU, United Arab Emirates
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Insights into adherence to cladribine tablets in the real world in multiple countries: results from patient support programs.
Journal: Therapeutic advances in neurological disorders
Published: June 03, 2025
Role of Immune Reconstitution Therapy with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in Older Patients.
Journal: Neurology and therapy
Published: April 08, 2025
Practical Recommendations from the Gulf Region on the Therapeutic Use of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis: Impact of the Latest Real-World Evidence on Clinical Practice.
Journal: Neurology and therapy
Published: June 18, 2024
Practical Guidance on the Use of Cladribine Tablets in the Management or Relapsing Multiple Sclerosis: Expert Opinion from Qatar.
Journal: Degenerative neurological and neuromuscular disease
Published: August 01, 2023
Multicentre Observational Study of Treatment Satisfaction with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in the Arabian Gulf: The CLUE Study.
Journal: Neurology and therapy
Published: March 29, 2023
Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19.
Journal: Neurology and therapy
Published: March 31, 2021
Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19.
Journal: Neurology and therapy
Published: March 31, 2021
Position of Cladribine Tablets in the Management of Relapsing-Remitting Multiple Sclerosis: An Expert Narrative Review From the United Arab Emirates.
Journal: Neurology and therapy
Published: February 05, 2021
High-efficacy therapies for relapsing-remitting multiple sclerosis: implications for adherence. An expert opinion from the United Arab Emirates.
Journal: Neurodegenerative disease management
Published: May 23, 2020
Disease-Modifying Drugs and Family Planning in People with Multiple Sclerosis: A Consensus Narrative Review from the Gulf Region.
Journal: Neurology and therapy
Published: May 01, 2020
Expert consensus from the Arabian Gulf on selecting disease-modifying treatment for people with multiple sclerosis according to disease activity.
Journal: Postgraduate medicine
Published: February 25, 2020
Management of relapsing-remitting multiple sclerosis in Qatar: an expert consensus.
Journal: Current medical research and opinion
Published: September 19, 2019
Last Updated: 09/26/2026